Analyst Ratings for Ionis Pharmaceuticals (IONS) [Neutrals]

IONS Rating Summary

IONS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IONS
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $47.53 (+21.1%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/10/2021 UBS Esther Rajavelu Upgrade Neutral
(Sell)
37.50
(33.00)
36.54
(39.25)
7.42% Details
3/1/2021 Barclays
» Updated 5/5/2022
Gena Wang Upgrade Equalweight
(Underweight)
36.00
(33.00)
53.41
(39.25)
-26.51% Details
Like IONS Ratings? Also take a look at BIIB, BCYC, PFE, DOV

IONS Ratings News